These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5121817)

  • 1. Intellectual and cognitive functions in Parkinson's disease.
    Reitan RM; Boll TJ
    J Consult Clin Psychol; 1971 Dec; 37(3):364-9. PubMed ID: 5121817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
    Jacobi P; Schneider E; Gundelsheimer W; Fischer PA
    Nervenarzt; 1974 Nov; 45(11):588-94. PubMed ID: 4453348
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of intellectual functioning of patients with Parkinson's disease using the Satz-Mogel (1962) short form of the Wechsler Adult Intelligence Scale.
    Albrecht NN; Netherton SD; Elias JW; Albrecht JW; Whitfield KE; Hutton JT
    Exp Aging Res; 1994; 20(2):155-72. PubMed ID: 8020542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in Parkinson's disease.
    Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intellectual impairments in patients with Parkinson's disease--a proposal of the subgroups of the disease].
    Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Shoda M
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1216-20. PubMed ID: 2605826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of stereotatic surgery on intelligence and personality in patients with Parkinson's disease.
    Christensen AL; Juul-Jensen P
    Acta Neurol Scand; 1967; 43(S31):174. PubMed ID: 4868156
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of levodopa therapy in Parkinson's disease. II. Measurement of behavioural changes.
    Radbill R; Rosenberg G; Schwartz A
    Can Med Assoc J; 1974 Dec; 111(11):1218-22. PubMed ID: 4434291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa treatment of Parkinson's syndrome. Improved intellectual functioning.
    Loranger AW; Goodell H; Lee JE; McDowell F
    Arch Gen Psychiatry; 1972 Feb; 26(2):163-8. PubMed ID: 5060402
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Weibing L; Kuwabara S
    J Neurol Sci; 2017 Aug; 379():18-21. PubMed ID: 28716237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent validity of the Test of Nonverbal Intelligence in Parkinson's disease patients.
    Bostantjopoulou S; Kiosseoglou G; Katsarou Z; Alevriadou A
    J Psychol; 2001 Mar; 135(2):205-12. PubMed ID: 11403342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychological assessmentof intelligence and personality in patients with Parkinsonism treated with basal ganglia surgery].
    Christensen AL; Juul-Jensen P; Malmros R; Harmsen A
    Ugeskr Laeger; 1968 Aug; 130(35):1427-37. PubMed ID: 5701094
    [No Abstract]   [Full Text] [Related]  

  • 12. Intellectual changes associated with levodopa therapy.
    Meier MJ; Martin WE
    JAMA; 1970 Jul; 213(3):465-6. PubMed ID: 5468023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Physiological trials with MIF-I in Parkinson's disease (author's transl)].
    Gonce M; Barbeau A
    Rev Neurol (Paris); 1978 Feb; 134(2):141-9. PubMed ID: 29330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and motor shifting aptitude disorder in Parkinson's disease.
    Cools AR; van den Bercken JH; Horstink MW; van Spaendonck KP; Berger HJ
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):443-53. PubMed ID: 6736974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual impairment in Parkinson's syndrome.
    Loranger AW; Goodell H; McDowell FH; Lee JE; Sweet RD
    Brain; 1972; 95(2):405-12. PubMed ID: 4655035
    [No Abstract]   [Full Text] [Related]  

  • 16. Intellectual impairment in Parkinson's disease--correlation with cerebral cortical blood flow.
    Yoshii F; Saitoh H; Takizawa S; Shinohara Y
    Tokai J Exp Clin Med; 1986 Nov; 11(5):361-9. PubMed ID: 3672565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.
    Bancher C; Braak H; Fischer P; Jellinger KA
    Neurosci Lett; 1993 Nov; 162(1-2):179-82. PubMed ID: 8121624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of intellectual faculties in Parkinson's disease].
    Nishikawa S; Harada H; Hikasa C; Yanagihara M; Takahashi K
    Rinsho Shinkeigaku; 1986 Jun; 26(6):568-73. PubMed ID: 3769306
    [No Abstract]   [Full Text] [Related]  

  • 20. General temperament and personality factors related to intellectual performances.
    Dreger RM
    J Genet Psychol; 1968 Dec; 113(2d Half):275-93. PubMed ID: 5720538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.